- Record: found
- Abstract: found
- Article: found
Clinical outcomes of patients with metastatic renal cell carcinoma (mRCC) treated with vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors (TKI) and mammalian target of rapamycin inhibitors (mTORI) after immuno-oncology (IO) checkpoint inhibitors
J. Graham ,
J.C. Wells ,
R. McKay ,
U.N. Vaishampayan ,
A. Hansen ,
F. Donskov ,
G.A. Bjarnason ,
B. Beuselinck ,
G. De Velasco ,
M.S. Duh ,
L. Huynh ,
R. Chang ,
G. Zanotti ,
K. Ramaswamy ,
T.K. Choueiri ,
D.Y.C. Heng
October 2018
October 2018
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.